Australian Clinical Labs
ACL.AX
#6702
Rank
A$0.72 B
Marketcap
$3.60
Share price
-1.64%
Change (1 day)
34.72%
Change (1 year)

Australian Clinical Labs (ACL.AX) - P/B ratio

P/B ratio as of November 2024 : 4.03

According to Australian Clinical Labs's latest financial reports the company has a price-to-book ratio of 1.047.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Australian Clinical Labs - P/B ratio (from 2022 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-313.4835.92%
2022-12-312.56